Search | Médecins Sans Frontières Access Campaign

60 results found

MSF Medical Doctor Ramya, conducting physical examination of female DRTB patient during her follow-up visit to endTB clinic.

Press release |

14 November 2023

MSF warns governments are failing to test, treat and prevent TB in children

Governments must immediately implement latest WHO guidelines to stop children dying from TB

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpert World Health Organization

GeneXpert test technology has revolutionised the diagnosis of TB, allowing detection of the TB bacterium, and its resistance to drugs, in only two hours.

Press release |

07 November 2023

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

Recent price reductions to WHO-recommended TB tests and treatment should enable more countries to make these vital medical tools available

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpertbedaquiline World Health Organization

Bibi Amina and her granddaughter Sayeeda wait to see a doctor at MSF's DR-TB hospital in Kandahar, Afghanistan, September 2022

Press release |

22 March 2023

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

MSF called on governments and donors to speed up access to diagnostic tests, and shorter, safer and more effective treatments, for DR-TB.

Tags Tuberculosis drug-resistant TB GeneXpert World Health Organization

Press release |

16 January 2023

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline

Ahead of the final hearing on a patent challenge by two TB survivors, MSF urges the Indian Patent Office to reject Johnson & Johnson’s secondary patent application so that other manufacturers may enter the supply chain with more ...

Tags Tuberculosis tuberculosis bedaquiline patent opposition World Health Organization India

MSF Counsellor, counselling parents of a six-year-old girl with drug-resistant TB at MSF independent Clinic, Mumbai- India

Press release |

27 October 2022

MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives

MSF reiterates that the price of a full DR-TB treatment course should be no more than US$500 per person.

Tags Tuberculosis tuberculosis World Health Organization

A Nurse examines medications in the storeroom at the TB Practecal Warehouse in Nukus, Uzbekistan.

Press release |

03 May 2022

MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multidrug-resistant TB

The World Health Organization (WHO) announced global treatment guidance with new, safer and more effective six-month oral treatment regimen for multidrug-resistant tuberculosis.

Tags Tuberculosis tuberculosis pretomanidlinezolidbedaquiline World Health Organization

Blog |

24 March 2022

The deadly gap in diagnosing children with tuberculosis

Drawing on Médecins Sans Frontières (MSF) extensive experience treating children with TB, our authors unpack some of the most important challenges in diagnosing paediatric TB, and how the updated WHO guidelines could improve the situation to save many more young lives.

Muhammad Yusuf (8) is undergoing a sputum induction in a specialized room in Paediatric TB hospital in Dushanbe. Analysing sputum culture is considered the best way to diagnose TB. However, children have great difficulty in producing it themselves.

Press release |

21 March 2022

MSF responds to updated WHO guidelines for tuberculosis in children

MSF highlights that TB diagnostic gap in children remains a major challenge, and urges countries to adopt WHO guidelines

Tags Tuberculosis tuberculosis GeneXpert World Health OrganizationCepheid

Letter |

08 October 2021

IJTLD: Urine LAM diagnostics can close the deadly testing gap for TB

TB LAM tests for TB diagnosis must be adopted by countries with high TB burden, and Abbott must make its current TB LAM test more accessible

Tags Tuberculosis tuberculosis World Health Organization

Press release |

03 September 2021

Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality

The WHO recently released new rapid guidance recommending that children of all ages with drug-resistant tuberculosis (DR-TB) have access to all-oral treatment using the drugs bedaquiline and/or delamanid. However paediatric ...

Tags Tuberculosis tuberculosis bedaquilinedelamanid World Health OrganizationJohnson & Johnson

Kam Thianlam (42) is an MDR-TB patient at MSF’s clinic in Churachandpur. He lives in Laisang, a remote place. Irene, MSF "Direct Observation Treatment Procedures" nurse, teaches MSF nurse teaches Akungmei, a newly recruited DOTs nurse how to administer the 15 tablets he needs to take everyday so that she can follow up his adherence.

Press release |

16 November 2020

Report shows new tests and drugs for world’s deadliest infectious disease, TB, remain out of reach

MSF calls on governments and donors to step up and speed up TB testing and treatment

Tags Tuberculosis drug-resistant TBtuberculosis World Health Organization

Nobuhle Titus, an MSF nurse technical support, packs sputum samples collected from a Luyanda site in the town of Vuma. Luyanda sites She collects and transports the samples from MSF’s Luyanda sites to the hospital where they are tested. Luyanda sites provide a link between patients and hospitals where patients can have sputum samples tested and receive information on TB and other diseases. This process makes the process of testing TB easier for patients who often stay far away from the hospital.

Press release |

14 October 2020

MSF response to the release of WHO Global TB Report 2020

The World Health Organization (WHO) released today the 2020 edition of its Global Tuberculosis (TB) Report. The report, which WHO releases annually, features data on disease trends and the response to the epidemic in 198 countries and ...

Tags Tuberculosis drug-resistant TBtuberculosis World Health Organization

Events |

20 May 2019

MSF at the 72nd World Health Assembly

Tags Antimicrobial resistanceResearch and developmentTuberculosis drug-resistant TBtuberculosis World Health AssemblyWorld Health Organization

Iryna Shchyra, deputy head of the pharmacy at the Zhytomyr Regional TB Dispensary, holds a bottle of bedaquiline.

Press release |

22 December 2018

As WHO issues new TB treatment guidelines, MSF calls for urgent scale-up of all-oral treatment

MSF welcomes new WHO treatment guidelines that recommend drug-resistant tuberculosis be treated with oral drugs only, including newer, more potent drugs with fewer side effects, such as bedaquiline.

Tags Tuberculosis drug-resistant TB bedaquilinedelamanid World Health OrganizationJohnson & Johnson

Nischaya, an XDR-TB patient, looking at her TB medication at the MSF clinic in Mumbai. Photograph by Atul Loke

Press release |

25 October 2018

Activists urge national TB programs and treatment providers to discontinue use of harmful injectable agents in TB treatment

Tags Tuberculosis drug-resistant TB linezolidbedaquilinedelamanid Union Conference on Lung HealthTreatment Action GroupWorld Health Organization Netherlands

Image of bedaquiline, TB drug at the MSF project in Osh, Kyrgyzstan, 2017.

Press release |

23 October 2018

MSF warns high prices of tuberculosis drugs restrict people's access to best drug-resistant TB treatment

We call on US pharma corporation Johnson & Johnson to cut key TB drug price in half

Tags Tuberculosis drug-resistant TB bedaquilinedelamanid patent pool Union Conference on Lung HealthWorld Health OrganizationJohnson & Johnson DRTB Drugs Under the Microscope Netherlands

A sputum sample analysis at the Blue House Clinic in Kenya, 2011.

Press release |

25 September 2018

Global leaders must make bold commitments at first-ever UN tuberculosis summit

Urgent need to scale up newer tools available today to save lives; and develop a fast, safe and simple cure for TB.

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline diagnostic testsresearch and development (R&D) World Health Organization

Kibera is one of the largest slums in Kenya. Here, MSF offers care to a neglected population isolated from basic healthcare standards due to hardships of poverty, Kenya 2011.

Press release |

18 September 2018

MSF response to release of WHO’s Global Tuberculosis Report 2018

The report highlights sluggish global progress on TB, indicating that countries will not be able to meet their targets in the ‘End TB’ strategy at this slow pace.

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline diagnostic tests World Health Organization

Letter |

17 September 2018

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

MSF sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant ...

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline WHO pre-qualification The Global Drug FacilityUNITAIDUSAIDWorld Health OrganizationJohnson & Johnson

XDR-TB patient Hanif, taking his daily TB medication at home in the Govandi area of Mumbai, 2016.

Press release |

17 August 2018

MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options

MSF calls on Johnson & Johnson to make key drug bedaquiline affordable for all people who need it.

Tags Tuberculosis drug-resistant TB bedaquiline World Health OrganizationJohnson & Johnson

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF warns governments are failing to test, treat and prevent TB in children

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline

MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives

MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multidrug-resistant TB

The deadly gap in diagnosing children with tuberculosis

MSF responds to updated WHO guidelines for tuberculosis in children

IJTLD: Urine LAM diagnostics can close the deadly testing gap for TB

Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality

Report shows new tests and drugs for world’s deadliest infectious disease, TB, remain out of reach

MSF response to the release of WHO Global TB Report 2020

MSF at the 72nd World Health Assembly

As WHO issues new TB treatment guidelines, MSF calls for urgent scale-up of all-oral treatment

Activists urge national TB programs and treatment providers to discontinue use of harmful injectable agents in TB treatment

MSF warns high prices of tuberculosis drugs restrict people's access to best drug-resistant TB treatment

Global leaders must make bold commitments at first-ever UN tuberculosis summit

MSF response to release of WHO’s Global Tuberculosis Report 2018

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options